2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Prostatic Neoplasms
29
Breast Neoplasms
28
Brain Neoplasms
21
Neoplasms
16
Glioma
10
Pancreatic Neoplasms
9
Head and Neck Neoplasms
8
Lymphoma
7
Uterine Cervical Neoplasms
6
Urinary Bladder Neoplasms
6
Rectal Neoplasms
6
Glioblastoma
6
Colonic Neoplasms
6
Carcinoma, Hepatocellular
6
Lymphoma, Non-Hodgkin
5
Lung Neoplasms
5
Astrocytoma
5
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Liver Neoplasms
4
Disease
4
Central Nervous System Neoplasms
4
Stomach Neoplasms
3
Spinal Cord Neoplasms
3
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Esophageal Neoplasms
3
Carcinoma in Situ
3
Retinoblastoma
2
Pathologic Complete Response
2
Interventions
gamma-Globulins
1
Tacrolimus
1
Salpingo-oophorectomy
1
Magnetic Resonance Imaging
1
Immunologic Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Paraneoplastic Syndromes
×
Magnetic Resonance Imaging
×
Clear all
NCT06915103
2025-04-08
A Case Report of NMDAR Encephalopathy
Mayo Clinic
Completed
1 enrolled